Journal
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Volume 47, Issue 1, Pages 13-27Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/S1040-8428(02)00213-5
Keywords
hepatocellular carcinoma; resection; liver surgery; review; primary liver tumours; treatment; outcome; recurrence
Categories
Ask authors/readers for more resources
Hepatocellular carcinoma (HCC) is a tumour of increasing incidence that usually arises in cirrhotic liver. Untreated, the prognosis is grim and the only curative treatment is surgical resection. The practical application of segmental surgery to the liver together with the use of ultrasound and other imaging techniques, patient selection criteria and improvements in perioperative technique and postoperative care have contributed to better results in hepatic surgery. Today, less than 10% mortality for resection of cirrhotic livers, with up to 50% 5-year survival rates are to be expected. However, the limits of resection for cure: intrahepatic recurrence makes stringent follow-up necessary. In this way the available modalities of treatment can be applied so as to improve survival. Herein, a current state-of-the-art of surgical indications and results for HCC is given. (C) 2003 Elsevier Science Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available